FOSTER CITY, California, May 6, 2016 /PRNewswire/ --
MedGenome will present its abstract titled 'SAGVDB - An integrated resource for South Asian genome variation' at the Big Data Bioinformatics Conference, to be held on May 26th-27th 2016 in Boston, MA.
A deep understanding of human genetic variation is essential for investigating the relationship between genotype and phenotype. The genetic sequence variations in individuals from different groups in South Asia is still not extensively explored. MedGenome's SAGVDB (South Asian Variation Database) comprises of 215 whole genomes and 121 whole exome from India, Pakistan, Sri Lanka and Bangladesh. The raw data compiled from various publications were processed using MedGenome's whole genome data analysis pipeline. The database contains ~ 34.2 million variants, of which ~ 31 million are SNPs and ~ 3.2 million are short InDels and includes variants from South Asian samples present in 1000-genome-phase3 and ExAC databases. The database also integrates variants from other studies including 1000-genome, ExAC, UK10K, GoNL, Iceland, EVS, 1000Japanese, Wellderly. In addition to showing allele frequencies, statistics for population/sub-population, a genome browser with adequate genome tracks, gene/transcript level annotation, etc. can enable researchers to dig deeper into the variants and their significance.
South Asian population, predominantly contributed by Indian sub-continent, represents a unique blend of genetically homogeneous, but socially and geographically stratified groups of individuals that can be leveraged to investigate complex diseases and disease phenotypes. MedGenome believes that the SAGVDB will be a great resource to enable further research into human diseases, identify new disease-causing variants, which will have a positive impact on global healthcare outcomes.
MedGenome (http://www.medgenome.com ) is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual's genome. Its unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized health care. MedGenome is a market leader for genomic diagnostics in South Asia and a leading provider of genomics research services globally. MedGenome is also a founding member of GenomeAsia 100K initiative to sequence 100,000 Genomes in South, North and East Asia.
This document contains certain forward-looking statements, other than the statements of research facts contained in this press release are forward looking statements. Terms such as "believe", "estimate", "anticipate", "plan", "predict", "may", "hope", "can", "will", "should", "expect", "intend", "is designed to", "with the intent", "potential", the negative of these words or such other variations thereon or comparable terminology, may indicate forward-looking statements, but their absence does not mean that a statement is not forward-looking. These forward-looking statements speak only as of the date of this press release. The events and circumstances reflected in MedGenome's forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, MedGenome does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
Director, Corporate Communications
Phone: 1-888-440-0954 Ext #: 102